Bristol Myers Squibb Co. Stock Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) shed 1.20% to $73.26 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.19% to 4,019.81 and the Dow Jones Industrial Average rising 0.76% to 33,629.56. The stock's fall snapped a two-day winning streak. Bristol Myers Squibb Co. closed $8.18 below its 52-week high ($81.44), which the company achieved on December 1st.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.25% to $168.31, Pfizer Inc. (PFE) fell 0.29% to $44.98, and Abbott Laboratories (ABT) rose 1.05% to $114.01. Trading volume (7.3 M) remained 1.8 million below its 50-day average volume of 9.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 23, 2023.
(END) Dow Jones Newswires
January 23, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.